Table 1.
Parameter | Baseline | TC Phase 1 | TC Phase 2 | p | Baseline | EC Phase 1 | EC Phase 2 | p |
---|---|---|---|---|---|---|---|---|
Systolic BP (mmHg) | 117 ± 5 | 126 ± 6 | 129 ± 5 | <0.001 | 119 ± 5 | 127 ± 6 | 133 ± 5 | <0.001 |
Diastolic BP (mmHg) | 67 ± 3 | 71 ± 3 | 73 ± 3 | <0.001 | 68 ± 4 | 72 ± 4 | 75 ± 5 | <0.001 |
Heart rate (bpm) | 64 ± 5 | 72 ± 6 | 76 ± 5 | <0.001 | 66 ± 6 | 71 ± 6 | 75 ± 8 | <0.001 |
MAP (mmHg) | 84 ± 3 | 90 ± 3 | 92 ± 3 | <0.001 | 84 ± 3 | 90 ± 3 | 94 ± 4 | <0.001 |
MSNA (bursts/min) | 23 ± 3 | 17 ± 3 | 17 ± 4 | <0.001 | 24 ± 3 | 16 ± 4 | 16 ± 3 | <0.001 |
SSNA (bursts/min) | 13 ± 2 | 22 ± 3 | 23 ± 3 | <0.001 | 13 ± 2 | 20 ± 2 | 22 ± 2 | <0.001 |
Plasma NE (pg/mL) | 168 ± 19 | 170 ± 22 | 182 ± 27 | 0.002 | 173 ± 22 | 185 ± 17 | 231 ± 30 | 0.003 |
BP, blood pressure; EC, electronic cigarette; MAP, mean arterial pressure; MSNA, muscle sympathetic nerve activity; NE, norepinephrine; SSNA, skin sympathetic nerve activity; TC, tobacco cigarette. p-values for differences within a session were obtained by post hoc tests (planned contrasts). Results are expressed as mean ± standard deviation (SD). All tests were two-sided and p < 0.002 was considered significant after Bonferroni adjustment for multiple comparisons.